Volume 28, Number 7—July 2022
Research
Self-Reported and Physiologic Reactions to Third BNT162b2 mRNA COVID-19 (Booster) Vaccine Dose
Figure 4

Figure 4. Self-reported and objective reactions following the third vaccine dose, stratified by age, sex, and underlying medical condition for self-reported and physiologic reactions to third BNT162b2 (Pfizer, https://www.pfizer.com) mRNA coronavirus disease vaccine doses. Reactions reported by participants through the mobile application (A, C, E) and objective heart rate and heart rate variability measured through a smartwatch (B, D, F) are shown, stratified by age (A, B), sex (C, D), and underlying medical condition (E, F). Bars indicate percentage of participants with a reported or recorded reaction; error bars indicate 90% CIs.
1These authors contributed equally to this article.